Publications

  • Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis

    Nicole Vincelette et al, Blood Cancer Discovery, 2024 View article

    Featured in: MYC expression in myelofibrosis, View video

    Featured in: Cancer Research Catalyst, View article

  • RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis

    Nana Adjoa Ben-Crentsil et al, Cancer Discovery, 2024 View article

  • Transcriptional Plasticity Drives IMiD and p300 Inhibitor Resistance in Multiple Myeloma

    Seongseok Yun et al, Blood Cancer Discovery, 2024 View article

  • Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML

    Onyee Chan et al, Blood Advances, 2024 View article

  • Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes

    Luis E. Aguirre et al, Clinical Lymphoma Myeloma & Leukemia, 2024 View article

  • Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities

    Nathan P Horvat et al, Annals of Hematology, 2023 View article

  • Integrative molecular subtypes of acute myeloid leukemia

    Qianxing Mo et al, Blood Cancer Journal, 2023 View article

  • Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia

    Parth C Patel et al, American Journal of Hematology, 2023 View article

  • Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

    Mario R Fernandez et al, Cancer Research, 2022 View article

  • TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia

    Seongseok Yun et al, Blood Cancer Discovery, 2021 View article

    Featured in: MYC and TFEB control DNA methylation and differentiation in AML, View commentary

  • Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)

    Seongseok Yun et al, Leukemia, 2021 View article

  • 4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells

    Seongseok Yun et al, Blood, 2016 View article

    Featured In: mTOR signaling: new networks for ALL, View commentary

  • Yun Lab Publications

    Click to View All Yun Lab Publications